Literature DB >> 15474329

The vascular endothelial growth factor family and its receptors.

Alexander A Parikh1, Lee M Ellis.   

Abstract

This article focuses on describing the biology of vascular endothelial growth factor (VEGF) and its receptors as well as the regulation of their expression. A thorough understanding of the VEGF system is paramount in optimizing antiangiogenic therapies as a component of antineoplastic regimens.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15474329     DOI： 10.1016/j.hoc.2004.06.004

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  19 in total

1.  Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.

Authors:  Ling Peng; Ping Zhan; Yun Zhou; Weijia Fang; Peng Zhao; Yulong Zheng; Nong Xu
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

Review 2.  Targeted approaches for the management of metastatic prostate cancer.

Authors:  Kathleen W Beekman; Maha Hussain
Journal:  Curr Oncol Rep       Date:  2006-05       Impact factor: 5.075

Review 3.  ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.

Authors:  Jiexin Deng; Jie Shao; John S Markowitz; Guohua An
Journal:  Pharm Res       Date:  2014-05-20       Impact factor: 4.200

4.  Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.

Authors:  Paola Di Gion; Friederike Kanefendt; Andreas Lindauer; Matthias Scheffler; Oxana Doroshyenko; Uwe Fuhr; Jürgen Wolf; Ulrich Jaehde
Journal:  Clin Pharmacokinet       Date:  2011-09       Impact factor: 6.447

5.  Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.

Authors:  Xiao-Wei Yu; Tian-Yi Wu; Xiang Yi; Wei-Ping Ren; Zu-bin Zhou; Yu-qiang Sun; Chang-qing Zhang
Journal:  Tumour Biol       Date:  2013-08-02

6.  Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate.

Authors:  Joan Manel Gasent Blesa; Enrique Grande Pulido; Juan Laforga Canales; Vicente Alberola Candel
Journal:  Case Rep Oncol       Date:  2009-12-11

7.  Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis.

Authors:  Ping Zhan; Qian Qian; Li-Ke Yu
Journal:  Hepatobiliary Surg Nutr       Date:  2013-06       Impact factor: 7.293

8.  Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis.

Authors:  Ping Zhan; Qian Qian; Li-Ke Yu
Journal:  Hepatobiliary Surg Nutr       Date:  2013-08       Impact factor: 7.293

9.  Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis.

Authors:  Ya-nan Ji; Qin Wang; Yang Li; Zhi Wang
Journal:  Tumour Biol       Date:  2014-03

10.  Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.

Authors:  Domingo G Perez; Vera J Suman; Tom R Fitch; Thomas Amatruda; Roscoe F Morton; Shamim Z Jilani; Costas L Constantinou; James R Egner; Lisa A Kottschade; Svetomir N Markovic
Journal:  Cancer       Date:  2009-01-01       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.